Anthem Biosciences
ANTHEM · Pharma > Pharmaceuticals & Drugs Listing date: July 21, 2025

Stock Price vs Company Growth
1d
1.1%
1w
2.4%
1m
10.1%
3m
16.6%
6m
20.6%
all
17.8%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 600 1.1%
587
737
Company Overview

Sales
1,954 Cr
Growth: 61.0%
Profit after Tax
554 Cr
Growth: 19.7%
Large Cap
33,725 Cr
P/E: 62.6x
Industry P/E: 30.0x
Fundamentals

Sales (Cr) ₹ 1,954
Growth 61.0%
EBITDA 37.1%
P/S 17.6x
Dividend 0.0%
P/E 62.6x
Book Value ₹ 2
PEG Ratio 1.0x
ROE 493.9%
P/B N/A
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

Anthem Biosciences has been set up as a Life sciences/ Biotechnology based venture specialising in the manufacture of catalytic preparation, other organic compounds such as speciality organic molecules, biologically active peptides etc., which are high-value products used in drug, agrochemical and speciality chemicals industries. Awards, accreditations, and recognition2023: Received a certificate of recognition as a ‘Four Star Export House’ from the Ministry of Commerce and Industry.
Followers (1)